For generations, women's health was one of medicine's least studied territories. That's changing, faster than most people realize.
84% of women said that once they found clearer answers about their health, they felt relieved, validated, and more in control.
Not better treated, or differently diagnosed—just informed. Given information that actually reflected what was happening in their body, and why. That number, from Mira's survey of 1,200 American women in May 2026, tells us something important: the problem was never that women's bodies are too complicated, but that the research wasn't being done.
That's changing.
For decades, women's health was medicine's blind spot
Here is a fact that still surprises people: until 1993, the US federal government did not require women to be included in clinical research trials funded by the NIH. For most of modern medicine's history, the default research subject was male. Drug dosages, diagnostic criteria, symptom profiles and "normal" ranges were all built on data that excluded women or treated them as a statistical afterthought.
The consequences were real. Women experience adverse drug reactions nearly twice as often as men. A landmark study of 6.9 million people found that women are diagnosed an average of four years later than men across hundreds of diseases. Endometriosis alone—affecting 1 in 10 women worldwide—takes between 7 and 10 years to diagnose on average. It has been undertreated for generations.
A 2023 McKinsey analysis estimated the global women's health gap costs the world economy $1 trillion a year in lost productivity and healthcare spend. The same analysis found that 34% of the total gap stems from disparities in care delivery—the system failing at every stage, not just access.
- 73% of women in Mira's 2026 survey said they turned to Google or ChatGPT for answers they couldn't get from a doctor.
- 77% said they felt overwhelmed or confused by conflicting information when they searched.
The maze was built from a century of research that forgot to include half the population, and now that era is ending.
What the research is finally showing
The last decade has produced a wave of women's health research that is beginning to fill the gap, from large academic studies to longitudinal real-world data that simply didn't exist before.
Hormonal variation is far wider and more meaningful than clinical practice acknowledged. A growing body of research is documenting that cycle length, ovulation timing, progesterone levels, and hormonal patterns vary significantly between women and across cycles in the same woman. Research published in npj Digital Medicine analyzing over 600,000 menstrual cycles found that only 13% of cycles were 28 days, and that cycle length varied by 7 or more days in most women over a year. The 28-day model is an average that most women don't match.
The hormonal roots of mood, cognition, and energy are being mapped. Research from the National Institute of Mental Health and others has established clear neurological mechanisms linking estrogen and progesterone fluctuations to serotonin, dopamine, and GABA signaling—the systems governing mood, anxiety, focus, and emotional regulation. What many women have been told is personality or stress is increasingly understood as a hormonal pattern with identifiable markers. This research is still reaching clinical practice slowly, meaning most women are ahead of their doctors on it.
PMOS (PCOS) is severely underdiagnosed, and the diagnostic picture is incomplete. Up to 70% of women with PMOS don't know they have it, according to research across multiple studies. The condition presents differently across cycle phases and across different body types, and standard diagnostic criteria (based on a single snapshot) frequently miss it. Researchers are now using continuous hormone tracking data to build a more nuanced picture of how PMOS actually manifests over time, rather than at one point in a doctor's office.
Perimenopause begins earlier than most women are told. Research published in Menopause and other leading journals documents that hormonal fluctuations characteristic of perimenopause can begin in the late 30s—up to 15 years before the final period. Most women experiencing these shifts are not told what's happening. They're often told they're too young for menopause, and sent away.
The investment is finally following the evidence. The Global Women's Health Innovation Conference (GWHIC) and others have tracked a significant shift in FemTech and women's health research funding since 2020—though the field still receives a fraction of the research dollars directed at conditions that affect men at comparable rates. The McKinsey report found that closing the women's health gap could unlock $1 trillion annually, creating pressure from both ethical and economic angles for the research community to move faster.
Real-world data is accelerating the shift
Academic studies set the direction, but the pace of understanding is being accelerated by a newer kind of data source: continuous, longitudinal hormone tracking from women monitoring their own cycles at home.
For the first time, researchers have access to daily hormone data across full cycles, across years of a woman's life—not clinical snapshots taken at standardized points in a lab. That changes what's measurable, and what questions can even be asked.
Analysis of large-scale cycle tracking datasets has confirmed several findings that women already suspected but had no data to support: for example, that ovulation is frequently absent or delayed (analysis of 211,000+ tracked cycles found 47% showed no clear ovulation signal in at least one month), that low progesterone is widespread and clinically under-recognized (22% of tracked cycles showed low PdG levels—with implications for both fertility and mental health), and that the cycle-to-cycle variation most women experience as anxiety-inducing irregularity is, in the vast majority of cases, entirely normal.
Mira's dataset—now spanning over 42 million hormone data points from continuous real-world tracking—is one of the largest of its kind, and is actively used by many research institutions to investigate hormonal patterns across fertility, perimenopause, PCOS, and cycle health. It's one piece of a larger research infrastructure that is, finally, building the evidence base women's health has lacked.
The direction of travel is clear. Women are no longer passive subjects in someone else's study. They are generating data about themselves, and that data is changing what medicine knows.
A generation that isn't waiting
This shift goes beyond research labs. It's also happening in the behavior of women themselves.
Searches for "predictive health" have risen 964% from 2022–2023 averages. Women aged 25–30 are now the most active health trackers—40% more engaged than women in their thirties, according to Mira's 2026 Women's Health Trends Report.
Gen Z is twice as likely as older generations to take health guidance from non-medical voices—not because they distrust doctors, but because they've learned that the specific, personalized answers they need often aren't available through standard care.
- 79% of women say they feel emotional support from online health communities.
- 86% believe women today are more proactive about their health than previous generations.
The frustration that built the maze is becoming the energy that dismantles it.
What changes when the data is yours
When a woman has real data about her own hormone patterns—not a population average, not a clinical snapshot, but her own continuous record—the dynamic of every health conversation she has changes. She knows what her baseline looks like, and she can see when something has shifted. She has something to bring to an appointment other than a description of how she feels—which is, historically, what gets dismissed.
- 73% of women delayed seeking care because they told themselves they were probably fine.
- 77% felt overwhelmed and confused navigating conflicting information alone. These numbers describe what happens when women navigate without data.
- The 84% who felt relief when they finally found answers showcases what happens when women do have the data.
That shift from guessing to knowing, from lost to oriented, is what the current wave of women's health research makes possible. The studies exist, the tools exist, and the data is being collected. And increasingly, it's available to individual women, not just to researchers.
The research was always about you
Every finding in these studies—about ovulation variability, about progesterone and mental health, about perimenopause beginning earlier than expected—describes something that is either happening in your body right now, or will be. The research gap that left women without answers for generations is closing. But closing slowly, and unevenly, and it hasn't yet reached most clinical encounters.
What tools like Mira offer is the individual version of that research: your hormone data, your cycle baseline, and your patterns over time. The kind of picture that turns is this normal? from a question you search at 2am into something you can actually answer for yourself.
The knowledge is being built. More of it should be yours.
